EDAP übertreffen die 19 der letzten 40Schätzungen.
48%
Nächster Bericht
Datum des nächsten Berichts
25. März 2026
Estimate forQ4 25(Revenue/ EPS)
$18.12M
/
-$0.12
Implizierte Änderung vonQ3 25(Revenue/ EPS)
+30.58%
/
-7.69%
Implizierte Änderung vonQ4 24(Revenue/ EPS)
-10.80%
/
+140.00%
EDAP TMS SA earnings per share and revenue
On 06. Nov. 2025, EDAP reported earnings of -0.13 USD per share (EPS) for Q3 25, beating the estimate of -0.21 USD, resulting in a 40.88% surprise. Revenue reached 13.88 million, compared to an expected 13.18 million, with a 5.32% difference. The market reacted with a -4.33% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of -0.12 USD, with revenue projected to reach 18.12 million USD, implying an decrease of -7.69% EPS, and increase of 30.58% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AngioDynamics, Inc.
Report Date
06. Jan. 2026 For Q2 26
Estimate
-$0.10
Aktuell
$0.00
Überraschung
+100.00%
FAQ
What were EDAP TMS SA's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, EDAP TMS SA reported EPS of -$0.13, beating estimates by 40.88%, and revenue of $13.88M, 5.32% above expectations.
How did the market react to EDAP TMS SA's Q3 2025 earnings?
The stock price moved down -4.33%, changed from $2.08 before the earnings release to $1.99 the day after.
When is EDAP TMS SA expected to report next?
The next earning report is scheduled for 25. März 2026.
What are the forecasts for EDAP TMS SA's next earnings report?
Based on 5
analysts, EDAP TMS SA is expected to report EPS of -$0.12 and revenue of $18.12M for Q4 2025.